Tumor Cells Chronically Treated with a Trastuzumab–Maytansinoid Antibody–Drug Conjugate Develop Varied Resistance Mechanisms but Respond to Alternate Treatments

Gespeichert in:

Bibliographische Detailangaben
Zeitschriftentitel:	Molecular Cancer Therapeutics
Personen und Körperschaften:	Loganzo, Frank, Tan, Xingzhi, Sung, Matthew, Jin, Guixian, Myers, Jeremy S., Melamud, Eugene, Wang, Fang, Diesl, Veronica, Follettie, Maximillian T., Musto, Sylvia, Lam, My-Hanh, Hu, William, Charati, Manoj B., Khandke, Kiran, Kim, Kenny Sung Kyoo, Cinque, Mike, Lucas, Judy, Graziani, Edmund, Maderna, Andreas, O'Donnell, Christopher J., Arndt, Kim T., Gerber, Hans-Peter
In:	Molecular Cancer Therapeutics, 14, 2015, 4, S. 952-963
Format:	E-Article
Sprache:	Englisch
veröffentlicht:	American Association for Cancer Research (AACR)
Schlagwörter:	Cancer Research Oncology

Online